Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-12-10

Clinical Trial Update: Nasal Fentanyl for Chronic Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 trial of nasal fentanyl for chronic cancer pain was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal fentanyl (fentanyl)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Cancer, Pain | Phase 3 | Status: WITHDRAWN